1. Home
  2. ARCT vs UPXI Comparison

ARCT vs UPXI Comparison

Compare ARCT & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • UPXI
  • Stock Information
  • Founded
  • ARCT 2013
  • UPXI 2018
  • Country
  • ARCT United States
  • UPXI United States
  • Employees
  • ARCT N/A
  • UPXI N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • ARCT Health Care
  • UPXI Health Care
  • Exchange
  • ARCT Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • ARCT 526.5M
  • UPXI 481.8M
  • IPO Year
  • ARCT N/A
  • UPXI 2021
  • Fundamental
  • Price
  • ARCT $7.34
  • UPXI $3.07
  • Analyst Decision
  • ARCT Buy
  • UPXI Buy
  • Analyst Count
  • ARCT 11
  • UPXI 1
  • Target Price
  • ARCT $38.67
  • UPXI $6.00
  • AVG Volume (30 Days)
  • ARCT 2.2M
  • UPXI 4.7M
  • Earning Date
  • ARCT 11-10-2025
  • UPXI 11-11-2025
  • Dividend Yield
  • ARCT N/A
  • UPXI N/A
  • EPS Growth
  • ARCT N/A
  • UPXI N/A
  • EPS
  • ARCT N/A
  • UPXI 1.85
  • Revenue
  • ARCT $97,601,000.00
  • UPXI $20,694,575.00
  • Revenue This Year
  • ARCT N/A
  • UPXI $145.75
  • Revenue Next Year
  • ARCT $26.81
  • UPXI N/A
  • P/E Ratio
  • ARCT N/A
  • UPXI $1.61
  • Revenue Growth
  • ARCT N/A
  • UPXI N/A
  • 52 Week Low
  • ARCT $7.26
  • UPXI $1.90
  • 52 Week High
  • ARCT $24.17
  • UPXI $22.57
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 26.87
  • UPXI 28.34
  • Support Level
  • ARCT $7.93
  • UPXI $3.15
  • Resistance Level
  • ARCT $9.29
  • UPXI $3.65
  • Average True Range (ATR)
  • ARCT 0.57
  • UPXI 0.34
  • MACD
  • ARCT -0.03
  • UPXI -0.04
  • Stochastic Oscillator
  • ARCT 0.31
  • UPXI 0.97

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.

Share on Social Networks: